Breaking News

DSM, SpineVision in Polymer Pact

March 20, 2013

DSM to license and supply Bionate II PCU

DSM has signed a license and supply agreement with SpineVision, a spinal implant and surgical systems developer, under which SpineVision will use DSM’s Bionate II PCU, a polymer, in its new Flex±2 system. The system is adaptable for various stages of intervertebral disc degeneration. DSM’s Bionate II PCU will be used to encapsulate the system with frontal and sagittal stabilization, helping to assure flexion and extension for increased mobility.
“The combination of design changes and the use of Bionate II PCU have enabled SpineVision to enhance the mechanical capabilities of the new Flex+2TM system leading to extended indications,” said Arnaud Brisard, chief executive officer, SpineVision.
“DSM’s polyurethane materials have a proven clinical history and have been used in several dynamic stabilization devices and implants,” said William Fuller, director of business development, DSM Biomedical. “Our Bionate II PCU provides increased flexibility and shock absorbing characteristics, replicating the natural movements of the spine. We are proud to see Bionate II PCU contributing to the performance of SpineVision’s Flex+2 system.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important